Title

Clinical Sensitivity of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Tests for Diagnosing Coronavirus Disease 2019.

Authors

Jessica P Ridgway
Jennifer Pisano
Emily Landon
Kathleen G Beavis
Ari Robicsek, Providence St. Joseph HealthFollow

Document Type

Article

Publication Date

8-1-2020

Publication Title

Open Forum Infect Dis

Keywords

2019-nCoV

Abstract

Utilizing 34 348 severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) nucleic acid amplification test (NAAT) results from 2 health systems, we estimated the clinical sensitivity of a single SARS-CoV-2 NAAT. We found that SARS-CoV-2 NAAT has 82%-97% sensitivity for diagnosing coronavirus disease 2019 among symptomatic patients.

Department

Infectious Diseases

Recommended Citation

Ridgway, Jessica P; Pisano, Jennifer; Landon, Emily; Beavis, Kathleen G; and Robicsek, Ari, "Clinical Sensitivity of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Tests for Diagnosing Coronavirus Disease 2019." (2020). Articles, Abstracts, and Reports. 3582.
https://digitalcommons.providence.org/publications/3582